Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Crowley

Showing results (161-170 of 178) with videos related to

Pageof 18
Sort By:
Blood|April 23, 2013
Risk factors for MDS and acute leukemia following total therapy 2 and 3 for multiple myelomaSaad Z Usmani, Jeffrey Sawyer, Adam Rosenthal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 28, 2009
Japanese-US common-arm analysis of paclitaxel plus carboplatin in advanced non-small-cell lung cancer: a model for assessing population-related pharmacogenomicsDavid R Gandara, Tomoya Kawaguchi, John Crowley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 14, 2007
Magnetic resonance imaging in multiple myeloma: diagnostic and clinical implicationsRonald Walker, Bart Barlogie, Jeffrey Haessler, et al.
British Journal of Haematology|June 27, 2007
Incorporating bortezomib into upfront treatment for multiple myeloma: early results of total therapy 3Bart Barlogie, Elias Anaissie, Frits van Rhee, et al.
European Journal of Haematology|February 14, 2016
Risk of skin cancer in multiple myeloma patients: a retrospective cohort studyAustin A Robinson, James Wang, Suzie Vardanyan, et al.
American Journal of Hematology|December 2, 2010
Prognostic factors and jaw and renal complications among multiple myeloma patients treated with zoledronic acidJames R Berenson, Ori Yellin, John Crowley, et al.
British Journal of Haematology|August 31, 2006
Long-term outcome results of the first tandem autotransplant trial for multiple myelomaBart Barlogie, Guido J Tricot, Frits van Rhee, et al.
Blood|February 5, 2011
Consensus recommendations for risk stratification in multiple myeloma: report of the International Myeloma Workshop Consensus Panel 2Nikhil C Munshi, Kenneth C Anderson, P Leif Bergsagel, et al.
British Journal of Haematology|July 19, 2012
Serum B-cell maturation antigen is elevated in multiple myeloma and correlates with disease status and survivalEric Sanchez, Mingjie Li, Alex Kitto, et al.
Blood|September 23, 2008
Genetic associations with thalidomide mediated venous thrombotic events in myeloma identified using targeted genotypingDavid C Johnson, Sophie Corthals, Christine Ramos, et al.
Pageof 18

Showing results (161-170 of 178) with videos related to

Sort By:
Pageof 18
Blood|April 23, 2013
Risk factors for MDS and acute leukemia following total therapy 2 and 3 for multiple myelomaSaad Z Usmani, Jeffrey Sawyer, Adam Rosenthal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 28, 2009
Japanese-US common-arm analysis of paclitaxel plus carboplatin in advanced non-small-cell lung cancer: a model for assessing population-related pharmacogenomicsDavid R Gandara, Tomoya Kawaguchi, John Crowley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 14, 2007
Magnetic resonance imaging in multiple myeloma: diagnostic and clinical implicationsRonald Walker, Bart Barlogie, Jeffrey Haessler, et al.
British Journal of Haematology|June 27, 2007
Incorporating bortezomib into upfront treatment for multiple myeloma: early results of total therapy 3Bart Barlogie, Elias Anaissie, Frits van Rhee, et al.
European Journal of Haematology|February 14, 2016
Risk of skin cancer in multiple myeloma patients: a retrospective cohort studyAustin A Robinson, James Wang, Suzie Vardanyan, et al.
American Journal of Hematology|December 2, 2010
Prognostic factors and jaw and renal complications among multiple myeloma patients treated with zoledronic acidJames R Berenson, Ori Yellin, John Crowley, et al.
British Journal of Haematology|August 31, 2006
Long-term outcome results of the first tandem autotransplant trial for multiple myelomaBart Barlogie, Guido J Tricot, Frits van Rhee, et al.
Blood|February 5, 2011
Consensus recommendations for risk stratification in multiple myeloma: report of the International Myeloma Workshop Consensus Panel 2Nikhil C Munshi, Kenneth C Anderson, P Leif Bergsagel, et al.
British Journal of Haematology|July 19, 2012
Serum B-cell maturation antigen is elevated in multiple myeloma and correlates with disease status and survivalEric Sanchez, Mingjie Li, Alex Kitto, et al.
Blood|September 23, 2008
Genetic associations with thalidomide mediated venous thrombotic events in myeloma identified using targeted genotypingDavid C Johnson, Sophie Corthals, Christine Ramos, et al.
Pageof 18